Biological therapy of chronic rhinosinusitis
Otorinolaryngologie a foniatrie · 2021
DOI: 10.48095/ccorl2021109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otorinolaryngologie a foniatrie, 2021. Verfasst von Zuzana Balatková und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The aim of this paper is to present an up-to-date information about therapeutical options in chronic rhinosinusitis with nasal polyps. First choice therapy is a long term regular application of intranasal steroids in combination with salinic solution douches. If this treatment is not eff ective enough, then the pulses of systemic steroids are indicated. If the sufficient control of the disease is not achieved, then surgery is a therapeutic choice; it means functional endoscopic sinus surgery in the extent corresponding to the extension of the sinus disease. However, there remains a certain group of patients in whom the results with this treatment are not optimal. The type 2 immunopathological response affects relevantly the course of the disease. Nowadays, the research is done in this field. Specific agents, which are able to block circulating inflammatory mediators or bind receptors for these mediators are developed and studied. The results of the studies having been completed by now are promising. Keywords: biological therapy – chronic rhinosinusitis – nasal polyps – dupilumab – immunoglobulin E – interleukin
Zitieren
APA
Balatková, Z., Knížek, Z., Vodička, J., & Plzák, J. (2021). Biological therapy of chronic rhinosinusitis. Otorinolaryngologie a foniatrie. https://doi.org/10.48095/ccorl2021109
Vancouver
Balatková Z, Knížek Z, Vodička J, Plzák J. Biological therapy of chronic rhinosinusitis. Otorinolaryngologie a foniatrie. 2021. doi:10.48095/ccorl2021109
BibTeX
@article{Balatkov2021,
author = {Balatková, Zuzana and Knížek, Zdeněk and Vodička, Jan and Plzák, Jan},
title = {Biological therapy of chronic rhinosinusitis},
journal = {Otorinolaryngologie a foniatrie},
year = {2021},
doi = {10.48095/ccorl2021109}
}
EUVIMED